Get started
Work

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial

Year: 2025
Type: article
Abstract: Dr. Bhatt has received research grant support to his institution from National Institutes of Health/National Heart, Lung, and Blood Institute, National Institutes of Health/National Institute on Aging, American College of Cardiology Foundation, and the Centers for Disease Control and Prevention and consulting fees from Heart Health Leaders, Sanofi Pasteur, Merck, Amgen, AstraZeneca and Novo Nordisk. Dr Vaduganathan has received research grant support, served on advisory boards, or had speaker engagements with American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, BMS, Boehringer Ingelheim, Chiesi, Cytokinetics, Fresenius Medical Care, Idorsia Pharmaceuticals, Lexicon Pharmaceuticals, Merck, Milestone Pharmaceuticals, Novartis, Novo Nordisk, Pharmacosmos, Relypsa, Roche Diagnostics, Sanofi, and Tricog Health; and participates on clinical trial committees for studies sponsored by Amgen, AstraZeneca, Boehringer Ingelheim, Galmed, Novartis, Bayer AG, Occlutech, Pharmacosmos, and Impulse Dynamics.
DOI: 10.1016/j.cardfail.2025.05.006
Authors: ANKEET S. BHATT, MUTHIAH VADUGANATHAN, BRIAN L. CLAGGETT, PARDEEP JHUND, ALASDAIR HENDERSON, CAROLYN S.P. LAM, MICHELE SENNI, SANJIV SHAH, AKSHAY DESAI, ADRIAAN A. VOORS, FAIEZ ZANNAD, BERTRAM PITT, ALANNA A. MORRIS, KATHARINA MUELLER, ANDREA SCALISE, JOHN J.V. MCMURRAY, SCOTT D. SOLOMON
Institutions: Kaiser Permanente, Kaiser Permanente Oakland Medical Center, Stanford Medicine, Stanford University, Brigham and Women's Hospital, University of Glasgow, National University of Singapore, Duke-NUS Medical School, National Heart Centre Singapore, Ospedale Papa Giovanni XXIII, University of Milano-Bicocca, Northwestern University, Northwestern Memorial Hospital, University Medical Center Groningen, University of Groningen, Inserm, Centre d'Investigation Clinique Pierre Drouin, French Clinical Research Infrastructure Network, Défaillance Cardiovasculaire Aiguë et Chronique, Université de Lorraine, University of Michigan, Michigan Medicine, Bayer (United States), Bayer (Germany)
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,970
Funder: Bayer
OpenAlex ID: W4410500374
FWCI: 0.701
Cites: 8
Cited by: 1
Related to: 10